ReviewDiseases (Basel, Switzerland)2026

First Reported Use of Recombinant Parathyroid Hormone in Kenny-Caffey Syndrome Type 2: A Case Report and Literature Review.

Maja Djordjevic Milosevic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.